Under the umbrella of the IFAPP Academy’s Value Added Programs and Services, offering continuing professional development initiatives and avenues for networking for our expanding learning community, the Conversations with the Academy webinar programs have garnered enthusiastic engagement.
In the third event in the series Dr. Mark Lightowler, CEO, Phorix Limited, highlighted The Role of Digital Tools in Changing Health Behavior, exploring the evidence for behavioral change parameters – e.g., physical activity, medication adherence, smoking cessation — to be considered in health outcome programs, in tandem with patient engagement tools. While evaluating how innovative digital tools are unlocking our understanding of behavior and our ability to change, Dr. Lightowler shared insights and resources to promote behavioral change in the workplace.
Following on, Dr. Birka Lehmann, Senior Expert Drug Regulatory Affairs, reviewed the New European Regulation for Clinical Trials, stressing the need for further legislative changes to drive a more harmonized approach by regulatory agencies granting clinical trials and Ethics Committees agreements. Dr. Lehmann outlined the transition with the regulations, which underscore the harmonization of conditions, emphasizing the new challenging interactions needed by regulatory agencies, Ethics Committees, and applicants. New timelines have to be respected by all involved partners. That e-handling of applications and approvals is imperative. Don’t miss the recording.
The panel discussion on Health Economics Outcomes Research, on December 17th, explored the evolving healthcare landscape and increasing expectations to demonstrate value. Subscribe to the Academy’s YouTube page to be notified once this recording has been posted.
We express our sincere appreciation for the invaluable inputs and contributions from our expert faculty and hosts. We are encouraged by your active participation at these events and look forward to your continued support and engagement.